COHANCE5 months ago
Cohance Lifesciences Limited (cohance) FY26 Q4 Results: Strategic Growth Alignment for FY27
Cohance Lifesciences Limited (COHANCE) reports FY26 Q4 results, showcasing strategic growth alignment and a transition year outlook for FY27.